1. Beth Israel Deaconess Medical Center

    0 Comments Leave a Comment

    1-15 of 32 1 2 »

    1. Mentioned In 32 Articles

    2. Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent Multimodality Imaging Through 3 Years

      Explore interventions.onlinejacc.org Cardiology
      Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent Multimodality Imaging Through 3 Years
      Objectives The aim of this study was to investigate the vascular responses and fates of the scaffold after bioresorbable vascular scaffold (BVS) implantation using multimodality imaging. Background Serial comprehensive image assessments after BVS implantation in the context of a randomized trial have not yet been reported. Methods In the ABSORB Japan trial, 400 patients were randomized to a BVS (n = 266) or a cobalt-chromium everolimus-eluting stent (n = 134). Through 3 ...
      Read Full Article
      Mentions: Beth Israel Deaconess Medical Center Columbia University Stanford University

    3. Beth Israel Deaconess Medical Center Receives NIH Grant for Intravascular Molecular-Structural Imaging of Coronary Stent Pathobiology

      Explore Optical Coherence Tomography News Cardiology , Funding
      Beth Israel Deaconess Medical Center Receives NIH Grant for Intravascular Molecular-Structural Imaging of Coronary Stent Pathobiology
      ... Eric Osborn. Below is a summary of the proposed work.  Dr. Eric Osborn is an early career faculty member at Beth Israel Deaconess Medical Center (BIDMC) and Massachusetts General Hospital (MGH), and an Instructor in Me...
      Read Full Article
      Mentions: Guillermo J. Tearney Beth Israel Deaconess Medical Center Massachusetts Institute of Technology

    4. Beth Israel Deaconess Medical Center Receives NIH Grant for Intravascular Molecular-Structural Imaging of Coronary Stent Pathobiology

      Explore Optical Coherence Tomography News Cardiology , Funding
      Beth Israel Deaconess Medical Center Receives NIH Grant for Intravascular Molecular-Structural Imaging of Coronary Stent Pathobiology
      ...f the proposed work.

      Dr. Eric Osborn is an early career faculty member at Beth Israel Deaconess Medical Center (BIDMC) and Massachusetts General Hospital (MGH), and an Instructor in Me...

      Read Full Article
      Mentions: Guillermo J. Tearney Beth Israel Deaconess Medical Center Massachusetts Institute of Technology

    5. SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FINDINGS AND VISUAL OUTCOME AFTER TREATMENT FOR VITREOMACULAR TRACTION

      Explore LWW Online Ophthalmology
      SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FINDINGS AND VISUAL OUTCOME AFTER TREATMENT FOR VITREOMACULAR TRACTION
      Purpose: To evaluate the capacity of spectral domain optical coherence tomography macular findings to predict best-corrected visual acuity (BCVA) outcomes after treatment for symptomatic vitreomacular traction. Methods: This consecutive, retrospective study included 24 patients (29 eyes) who experienced vitreomacular traction release with pneumatic vitreolysis (n = 9), intravitreal ocriplasmin (n = 6), or pars plana vitrectomy (n = 14). Preoperative and postoperative spectral domain optical coherence tomography images were used to determine the ...
      Read Full Article
      Mentions: Beth Israel Deaconess Medical Center Harvard University

    7. Is quantitative coronary angiography reliable in assessing the late lumen loss of the everolimus eluting bioresorbable polylactide scaffold in comparison with the cobalt chromium metallic stent?

      Explore eurointervention.org Cardiology
      Is quantitative coronary angiography reliable in assessing the late lumen loss of the everolimus eluting bioresorbable polylactide scaffold in comparison with the cobalt chromium metallic stent?
      Aims: Immediately after stent/scaffold implantation, quantitative coronary angiography (QCA) with respect to optical coherence tomography (OCT) more severely underestimates the lumen diameter (LD) in Absorb than in XIENCE. This OCT-QCA discrepancy has not been evaluated at long-term follow-up. The present study aimed to assess the accuracy of QCA with reference to OCT in Absorb as compared to XIENCE.
      Read Full Article
      Mentions: Beth Israel Deaconess Medical Center Columbia University Leiden University

    8. Beth Isreal Deaconess Medical Center Receives Grant for Intravascular Molecular-Structural Imaging of Coronary Stent Pathobiology

      Explore Optical Coherence Tomography News Cardiology , Funding
      Beth Isreal Deaconess Medical Center Receives Grant for Intravascular Molecular-Structural Imaging of Coronary Stent Pathobiology
      ...of the propose work.

      Dr. Eric Osborn is an early career faculty member at Beth Israel Deaconess Medical Center (BIDMC) and Massachusetts General Hospital (MGH), and an Instructor in Me...

      Read Full Article
      Mentions: Guillermo J. Tearney Beth Israel Deaconess Medical Center Massachusetts Institute of Technology

    10. Collar Sign in Incompletely Occluded Aneurysms after Pipeline Embolization: Evaluation with Angiography and Optical Coherence Tomography

      Explore American Journal of Neuroradiology Neurology
      Collar Sign in Incompletely Occluded Aneurysms after Pipeline Embolization: Evaluation with Angiography and Optical Coherence Tomography
      BACKGROUND AND PURPOSE: Flow diversion with the Pipeline Embolization Device has emerged as an attractive treatment for cerebral aneurysms. Processes involved in aneurysm occlusion include changes in intra-aneurysmal hemodynamics and endothelialization of the device. Here, we call attention to a radiographic sign not previously reported that is detected in incompletely occluded aneurysms after treatment with the Pipeline Embolization Device at angiographic follow-up and referred to as the collar sign. MATERIALS ...
      Read Full Article
      Mentions: Beth Israel Deaconess Medical Center Harvard University

    11. Targeted Near-Infrared Fluorescence Imaging of Atherosclerosis

      Explore ScienceDirect Cardiology
      Targeted Near-Infrared Fluorescence Imaging of Atherosclerosis
      Objectives This study sought to determine whether indocyanine green (ICG)enhanced near-infrared fluorescence (NIRF) imaging can illuminate high-risk histologic plaque features of human carotid atherosclerosis, and in coronary atheroma of living swine, using intravascular NIRF-optical coherence tomography (OCT) imaging. Background New translatable imaging approaches are needed to identify high-risk biological signatures of atheroma. ICG is a U.S. Food and Drug Administrationapproved NIRF imaging agent that experimentally targets plaque macrophages ...
      Read Full Article
      Mentions: Guillermo J. Tearney Beth Israel Deaconess Medical Center Brigham and Women’s Hospital

    12. The new kid on the block for advanced imaging in Barrett’s esophagus: a review of volumetric laser endomicroscopy

      Explore Therapeutic Advances in Gastroenterology Gastroenterology
      The new kid on the block for advanced imaging in Barrett’s esophagus: a review of volumetric laser endomicroscopy
      Advanced imaging techniques used in the management of Barretts esophagus include electronic imaging enhancement (e.g. narrow band imaging, flexible spectral imaging color enhancement, and i-Scan), chromoendoscopy, and confocal laser endomicroscopy. Electronic imaging enhancement is used frequently in daily practice, but use of the other advanced technologies is not routine. High-definition white light endoscopy and random four quadrant biopsy remain the standard of care for evaluation of Barretts esophagus; this ...
      Read Full Article
      Mentions: Beth Israel Deaconess Medical Center Harvard University NinePoint Medical

    13. NinePoint Medical Announces FDA 510(k) Clearance of a Real-Time Targeting Feature for the NvisionVLE® Imaging System and the First Clinical Cases in the U.S.

      Explore Optical Coherence Tomography News Gastroenterology
      NinePoint Medical Announces FDA 510(k) Clearance of a Real-Time Targeting Feature for the NvisionVLE® Imaging System and the First Clinical Cases in the U.S.
      ...come an integral part of the care of my patients with esophageal disease,” stated Dr. Douglas K. Pleskow, MD, Beth Israel Deaconess Medical Center, Associate Clinical Professor of Medicine, Harvard Medical School. “The a...
      Read Full Article
      Mentions: Beth Israel Deaconess Medical Center Harvard University FDA

    14. Dual modality intravascular optical coherence tomography (OCT) and near-infrared fluorescence (NIRF) imaging: a fully automated algorithm for the distance-calibration of NIRF signal intensity for quantitative molecular imaging

      Explore Home - Springer
      Dual modality intravascular optical coherence tomography (OCT) and near-infrared fluorescence (NIRF) imaging: a fully automated algorithm for the distance-calibration of NIRF signal intensity for quantitative molecular imaging
      ...e Netherlands Department of Biomedical Engineering, Boston University, Boston, MA, USA Cardiology Division, Beth Israel Deaconess Medical Center, Boston, MA, USA Department of Pathology, Harvard Medical School and Mas...
      Read Full Article
      Mentions: Guillermo J. Tearney Beth Israel Deaconess Medical Center Massachusetts Institute of Technology

    15. Massachusetts Institute of Technology receives a 2012 NIH Grant for Optical Biopsy Using Optical Coherence Tomography

      Explore Optical Coherence Tomography News Funding
      Massachusetts Institute of Technology receives a 2012 NIH Grant for Optical Biopsy Using Optical Coherence Tomography
      ...linical studies in a collaborative effort between investigators at the Massachusetts Institute of Technology, Beth Israel Deaconess Medical Center, Boston VA Healthcare System, and Harvard Medical School. The specific ai...
      Read Full Article
      Mentions: Beth Israel Deaconess Medical Center Massachusetts Institute of Technology National Institutes of Health
    17. 1-15 of 32 1 2 »
  1. Search:

  2. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology

    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents

    3. Technology:

      Broadband Sources, Probes, Tunable Sources

    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks

  4. About Beth Israel Deaconess Medical Center

    Beth Israel Deaconess Medical Center

    Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts is a major teaching hospital of Harvard Medical School. It was formed out of the 1996 merger of Beth Israel Hospital (founded in 1916) and New England Deaconess Hospital (founded in 1896). Among independent teaching hospitals, Beth Israel Deaconess Medical Center is the third-largest recipient of biomedical research funding from the National Institutes of Health.

  5. Related Topics

    1. Ex vivo imaging of human thyroid pathology using integrated optical coherence tomography and optical coherence microscopy
      19 articles also mentioned Harvard University
    2. In vivo endomicroscopy using three-dimensional optical coherence tomography and Fourier domain mode locked lasers
      17 articles also mentioned Massachusetts Institute of Technology
    3. Ex vivo imaging of human pathologies with integrated optical coherence tomography (OCT) and optical coherence microscopy (OCM)
      7 articles also mentioned Chao Zhou